These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10102058)

  • 21. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height.
    van Gool SA; Kamp GA; Odink RJ; de Muinck Keizer-Schrama SM; Delemarre-van de Waal HA; Oostdijk W; Wit JM
    Eur J Endocrinol; 2010 Apr; 162(4):653-60. PubMed ID: 20110402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose effects of growth hormone during puberty.
    Saenger P
    Horm Res; 2003; 60(Suppl 1):52-7. PubMed ID: 12955018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
    Satoh M; Tanaka T; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
    Khadilkar V; Radjuk KA; Bolshova E; Khadgawat R; El Kholy M; Desai M; Peterkova V; Mericq V; Kratzsch J; Siepl EC; Martin D; Lopez P; Ji HJ; Bae YJ; Lee JH; Saenger PH
    J Clin Endocrinol Metab; 2014 Jan; 99(1):126-32. PubMed ID: 24170106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency.
    Coelho R; Brook CG; Preece MA; Stanhope RG; Dattani MT; Hindmarsh PC
    Horm Res; 2008; 70(2):85-8. PubMed ID: 18547954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: a randomized controlled study.
    Soliman AT; abdul Khadir MM
    J Trop Pediatr; 1996 Oct; 42(5):281-6. PubMed ID: 8936959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F; Berberoğlu M; Ocal G; Adiyaman P; Bundak R; Günöz H; Baş F; Darcan S; Gökşen D; Arslanoğlu I; Yildiz M; Ercan O; Ercan G; Ozerkan E; Can S; Böber E; Adal E; Sarikaya S; Dallar Y; Siklar Z; Bircan I; Bideci A; Yüksel B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final height of growth hormone-treated patients with growth hormone deficiency: the North American experience.
    Hintz RL
    Acta Paediatr Suppl; 1999 Feb; 88(428):70-1. PubMed ID: 10102056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiation.
    Rogol AD; Cohen P; Weng W; Kappelgaard AM; Germak JA
    Horm Res Paediatr; 2013; 80(1):28-37. PubMed ID: 23816571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
    Lindgren AC; Ritzén EM
    Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey.
    Job JC; Chaussain JL; Garnier P; Rolland A; Joab N
    Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.